Rule 480-27-.02 - Prescription Drug Order Requirements(1) Prescription drug orders shall include, but not be limited to, the following information: (b) Name and address of patient (or patient location if in an institution);(c) Name, address, and telephone number of the prescriber;(d) DEA registration number of the prescriber in the case of controlled substances;(e) Name, strength, dosage form and quantity of drug prescribed;(f) Number of authorized refills;(g) Directions for use by patient;(h) If a written prescription drug order, the signature of the prescribing practitioner; and(i) Any cautionary statements as may be required or necessary.(2) Electronically transmitted prescription drug orders shall contain all information required for written prescriptions above and required by state and federal law including the prescriber's name, address, and phone number, except the signature may be an electronic signature as provided below and the electronically transmitted prescription must include the time and date of transmission.(a) Electronically transmitted prescription drug orders transmitted from the practitioner and received by a pharmacy via facsimile must contain either an electronically reproduced visual image signature or original signature of the practitioner.(b) Electronically generated prescription drug orders transmitted from the practitioner and received by a pharmacy as e-mails must contain an electronic data signature of the practitioner.(c) All electronic prescription drug orders generated by a practitioner containing an electronically reproduced visual image signature or an electronic data signature must bear wording that appears on the face of the prescription which indicates the signature was electronically generated.(3) The pharmacist shall exercise professional judgment regarding the accuracy and authenticity of prescriptions consistent with federal and state statutes and regulations. In the absence of unusual circumstances requiring further inquiry, the pharmacy and each of its associated pharmacists are entitled to rely on the accuracy and authenticity of electronically transmitted prescriptions from an intervening electronic for matter that comply with this rule.(4) An electronic visual image prescription drug order that bears an electronic reproduction of the visual image of the practitioner's signature and is given directly to the patient must be printed on security paper with the wording that indicates the signature was electronically generated.(a) Every hard copy prescription drug order for any Schedule II controlled substance written in this state by a practitioner shall be written on security paper. If a hard copy of an electronic data prescription drug order for any Schedule II controlled substance is given directly to the patient, the manually signed hard copy prescription drug order must be on security paper.(5) Pharmacies are prohibited from receiving electronic data from intervening electronic for matters that do not meet all of the following requirements:(a) Utilize recognized encrypted technology and secure servers.(b) Maintain HIPAA compliance.(c) Maintain a combination of technical and administrative security measures, such as, but not limited to those listed in Security Standards for the Protection of Electronic Protected Health Information (HIPAA), to ensure a reasonable and appropriate level of: 1. Practitioner and dispenser authentication;2. Content integrity; and(d) Refrain from collecting and disseminating patient and/or prescriber data to sources other than the originating prescriber and the receiving pharmacy.Ga. Comp. R. & Regs. R. 480-27-.02
O.C.G.A. §§ 16-13-41, 16-13-73, 16-13-74, 26-4-5, 26-4-27, 26-4-28, 26-4-37, 26-4-80, 26-4-80.1, 26-4-83, 42 C.F.R. Part 423 .
Original Rule entitled "Prescription Requirements" adopted. F. Nov. 26, 1986; eff. Dec. 16, 1986.Repealed: New Rule entitled "Prescription Drug Order Requirements" adopted. F. July 24, 2002; eff. August 13, 2002.Repealed: New Rule of same title adopted. F. Aug. 18, 2006; eff. Sept. 7, 2006.Amended: F. Jan. 23, 2009; eff. Feb. 12, 2009.Amended: F. July 27, 2015; eff. August 16, 2015.Amended: F. May 20, 2023; eff. June 9, 2023.